Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 10, 2021 16:15 ET | Source: Vyant Bio, Inc.

Vyant Bio to Present at the Q4 Investor Summit Micro & Small Cap Conference

Cherry Hill, N.J., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), an emerging global drug discovery company, is rapidly identifying small and large...
November 09, 2021 09:15 ET | Source: Vyant Bio, Inc.

Vyant Bio Announces Investor Conference Call and Webcast for the Third Quarter 2021

CHERRY HILL, N.J., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), an emerging global drug discovery company, is rapidly identifying small and large...
October 26, 2021 08:00 ET | Source: Vyant Bio, Inc.

Vyant Bio Announces Robert T. Fremeau, Jr. Ph.D. as Chief Scientific Officer

Cherry Hill, N.J., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), an emerging global drug discovery company identifying small and large molecule...
August 11, 2021 09:00 ET | Source: Vyant Bio, Inc.

Vyant Bio Announces Investor Conference Call and Webcast for Second Quarter 2021

CHERRY HILL, N.J., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), an emerging global drug discovery company, is rapidly identifying small and large...